HealthEquity Reports Second Quarter Results, Raises WageWorks Synergy Target

Rhea-AI Summary

HealthEquity (NASDAQ: HQY) reported impressive Q2 results for the fiscal year ending July 31, 2020, with revenue reaching $176.0 million, a 103% increase from $86.6 million in Q2 FY20. Despite a net loss of $0.1 million, the company achieved a non-GAAP net income of $30.1 million, or $0.42 per diluted share. Adjusted EBITDA was $60.0 million, up 48% year-over-year. Total HSA Assets grew to $12.2 billion, reflecting a 43% year-over-year increase. HealthEquity also completed its WageWorks acquisition, surpassing synergy targets with an increased target of $80 million.

Positive

• Revenue grew 103% year over year to $176.0 million.
• Non-GAAP net income reached $30.1 million, a significant increase from Q2 FY20.
• Adjusted EBITDA rose 48% to $60.0 million; EBITDA margin improved to 34%.
• Total HSA Assets increased 43% to $12.2 billion.
• Account metrics showed strong growth: 5.4 million HSAs and 12.5 million total accounts.

Negative

• Net loss of $0.1 million, contrasting with previous year’s net income of $19.4 million.
• Adjusted EBITDA margin decreased from 47% in Q2 FY20 to 34%.

Highlights of the second quarter include:

• Revenue of $176.0 million, an increase of 103% compared to $86.6 million in Q2 FY20.
• Net loss of $0.1 million, with non-GAAP net income of $30.1 million, compared to net income of $19.4 million and non-GAAP net income of $28.8 million in Q2 FY20.
• Net loss per diluted share of less than one half of one cent, with non-GAAP net income per diluted share of $0.42, compared to net income per diluted share of $0.30 and non-GAAP net income per diluted share of $0.44 in Q2 FY20.
• Adjusted EBITDA of $60.0 million, an increase of 48% compared to $40.6 million in Q2 FY20.
• 5.4 million HSAs, an increase of 29% compared to Q2 FY20.
• $12.2 billion Total HSA Assets, an increase of 43% compared to Q2 FY20.
• 12.5 million Total Accounts, including both HSAs and complementary CDB accounts, an increase of 158% compared to Q2 FY20.
• The Company sold 5,290,000 shares of common stock, yielding net proceeds of $286.8 million.

DRAPER, Utah, Sept. 08, 2020 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") non-bank custodian, today announced financial results for its second quarter ended July 31, 2020, compared to its prior quarter ended July 31, 2019, which did not include the acquisition of WageWorks.

“The HealthEquity team delivered strong results this quarter despite the pandemic. Adjusted EBITDA of $60 million, a sequential increase in adjusted EBITDA margin to 34%, and robust sales speak to the margin and growth opportunities of our business,” said Jon Kessler, President and CEO of HealthEquity. “Team Purple delivered for our members, clients and partners, growing HSA Assets sequentially by over $700 million, a second quarter record, and maintaining the high level of service HealthEquity is known for even as 97% of team members worked from home.”

Second quarter financial results

Revenue for the second quarter ended July 31, 2020 of $176.0 million grew 103% compared to $86.6 million for the second quarter ended July 31, 2019. Revenue this quarter included: service revenue of $103.8 million, custodial revenue of $46.9 million, and interchange revenue of $25.3 million.

HealthEquity reported a net loss of $0.1 million, or less than one half of one cent per diluted share, and non-GAAP net income of $30.1 million, or $0.42 per diluted share, for the second quarter ended July 31, 2020. The Company reported net income of $19.4 million, or $0.30 per diluted share, and non-GAAP net income of $28.8 million, or $0.44 per diluted share, for the second quarter ended July 31, 2019.

Adjusted EBITDA was $60.0 million for the second quarter ended July 31, 2020, an increase of 48% compared to $40.6 million for the second quarter ended July 31, 2019. Adjusted EBITDA was 34% of revenue compared to 47% for the second quarter ended July 31, 2019.

Account and asset metrics

HSAs as of July 31, 2020 were approximately 5.4 million, an increase of 29% year over year, including 284,000 HSAs with investments, an increase of 52% year over year. Total Accounts as of July 31, 2020 were 12.5 million, including 7.1 million consumer-directed benefit ("CDB") accounts.

Total HSA Assets as of July 31, 2020 were $12.2 billion, an increase of 43% year over year. Total HSA Assets included $9.0 billion of HSA cash and $3.2 billion of HSA investments. Client-held funds, which are deposits held on behalf of our Clients to facilitate administration of our CDBs, and from which we generate custodial revenue, were $0.8 billion as of July 31, 2020.

New HSA openings and HSA asset balances

HealthEquity reported sales of 108,000 new HSAs in the second quarter ended July 31, 2020, compared to 126,000 in the second quarter ended July 31, 2019. HSA members grew their cash balances by approximately $246.0 million during the quarter, while total member balances increased by approximately $707.0 million due primarily to decreased spending per HSA and appreciation of invested balances.

WageWorks integration and increased synergy target

HealthEquity completed its acquisition of WageWorks on August 30, 2019. The Company accelerated its integration efforts and achieved its previously stated goal of $50 million in run rate synergies by the end of this second quarter, more than a year ahead of schedule. We also successfully migrated five legacy platforms and approximately $1 billion in HSA assets to our legacy HealthEquity HSA platform. In addition, we completed the return of all service calls to the United States.

In light of this progress, the Company raised its net synergy target to $80 million, to be achieved over the next 18 months.  Said Ted Bloomberg, Chief Operating Officer of HealthEquity, “Consolidating to a single platform for the delivery of our total solution will enable our members, clients and partners to better connect health and wealth, while increasing the efficiency and focus of our team.”

Business outlook

For the fiscal year ending January 31, 2021, management expects revenues of $720 million to $730 million. Its outlook is for net loss between $13 million and $5 million, resulting in net loss per diluted share of $0.17 to $0.08. Its outlook for non-GAAP net income, calculated using the method described below, is between $111 million and $119 million, resulting in non-GAAP net income per diluted share of $1.48 to $1.58 (based on an estimated 75 million weighted-average shares outstanding). Management expects Adjusted EBITDA of $226 million to $236 million.

See “Non-GAAP financial information” below for definitions of our Adjusted EBITDA and non-GAAP net income. A reconciliation of the non-GAAP financial measures used throughout this release to the most comparable GAAP financial measures is included with the financial tables at the end of this release.

Conference call

HealthEquity management will host a conference call at 4:30 pm (Eastern Time) on Tuesday, September 8, 2020 to discuss the second quarter 2021 financial results. The conference call will be accessible by dialing 844-791-6252, or 661-378-9636 for international callers, and referencing conference ID 5170518. A live audio webcast of the call will also be available on the investor relations section of our website at http://ir.healthequity.com.

Non-GAAP financial information

To supplement our financial information presented on a GAAP basis, we disclose non-GAAP financial measures, including Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per diluted share.

• Adjusted EBITDA is adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration and acquisition-related costs, gains and losses on marketable equity securities, and other certain non-operating items.
• Non-GAAP net income is calculated by adding back to net income before provision for income taxes the following items: amortization of acquired intangible assets, stock-based compensation expense, merger integration and acquisition-related costs, and gains and losses on marketable equity securities.
• Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.

Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP and should not be considered as a substitute for, or superior to, GAAP results. We believe that these non-GAAP financial measures provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company cautions investors that non-GAAP financial information, by its nature, departs from GAAP; accordingly, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. In addition, while amortization of acquired intangible assets is being excluded from non-GAAP net income, the revenue generated from those acquired intangible assets is not excluded. Whenever we use these non-GAAP financial measures, we provide a reconciliation of the applicable non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed in the tables below.

About HealthEquity

HealthEquity administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million members in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable “Purple” service. For more information, visit www.healthequity.com.

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

• the impact of the ongoing COVID-19 pandemic on the Company, its operations and its financial results;
• our ability to realize the anticipated financial and other benefits from combining the operations of WageWorks with our business in an efficient and effective manner;
• our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
• our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;
• our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
• the significant competition we face and may face in the future, including from those with greater resources than us;
• our reliance on the availability and performance of our technology and communications systems;
• recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
• the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
• our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;
• our reliance on partners and third-party vendors for distribution and important services;
• our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;
• our ability to protect our brand and other intellectual property rights; and
• our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, our Quarterly Report on Form 10-Q for the quarter ended April 30, 2020, and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations Contact
Richard Putnam
801-727-1209
rputnam@healthequity.com

HealthEquity, Inc. and its subsidiaries
Condensed consolidated balance sheets
(in thousands, except par value)		July 31, 2020				January 31, 2020
		(unaudited)
Assets
Current assets
Cash and cash equivalents	$	268,910			$	191,726
Accounts receivable, net of allowance for doubtful accounts of $1,954 and $1,216 as of July 31, 2020 and January 31, 2020, respectively	70,235				70,863
Other current assets	43,982				34,711
Total current assets	383,127				297,300
Property and equipment, net	34,528				33,486
Operating lease right-of-use assets	95,095				83,178
Intangible assets, net	783,106				783,279
Goodwill	1,333,808				1,332,631
Deferred tax asset	59				18
Other assets	34,658				35,089
Total assets	$	2,664,381			$	2,564,981
Liabilities and stockholders’ equity
Current liabilities
Accounts payable	$	11,708			$	3,980
Accrued compensation	36,435				50,121
Accrued liabilities	37,424				46,372
Current portion of long-term debt	54,688				39,063
Operating lease liabilities	13,521				12,401
Total current liabilities	153,776				151,937
Long-term liabilities
Long-term debt, net of issuance costs	952,898				1,181,615
Operating lease liabilities, non-current	79,304				68,017
Other long-term liabilities	8,210				2,625
Deferred tax liability	129,857				130,492
Total long-term liabilities	1,170,269				1,382,749
Total liabilities	1,324,045				1,534,686
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of July 31, 2020 and January 31, 2020, respectively	—				—
Common stock, $0.0001 par value, 900,000 shares authorized, 76,872 and 71,051 shares issued and outstanding as of July 31, 2020 and January 31, 2020, respectively	8				7
Additional paid-in capital	1,127,136				818,774
Accumulated earnings	213,192				211,514
Total stockholders’ equity	1,340,336				1,030,295
Total liabilities and stockholders’ equity	$	2,664,381			$	2,564,981

HealthEquity, Inc. and its subsidiaries
Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)
	Three months ended July 31,								Six months ended July 31,
(in thousands, except per share data)		2020				2019				2020				2019
Revenue
Service revenue	$	103,805			$	26,282			$	215,076			$	53,090
Custodial revenue	46,909				43,614				93,808				85,566
Interchange revenue	25,325				16,727				57,166				35,019
Total revenue	176,039				86,623				366,050				173,675
Cost of revenue
Service costs	65,246				19,745				136,259				40,394
Custodial costs	4,998				4,209				10,043				8,332
Interchange costs	4,011				4,229				9,890				8,756
Total cost of revenue	74,255				28,183				156,192				57,482
Gross profit	101,784				58,440				209,858				116,193
Operating expenses
Sales and marketing	12,167				8,391				23,622				17,361
Technology and development	30,654				11,645				61,732				22,550
General and administrative	20,493				9,262				39,491				17,971
Amortization of acquired intangible assets	19,077				1,494				37,779				2,985
Merger integration	10,365				2,784				23,135				2,784
Total operating expenses	92,756				33,576				185,759				63,651
Income from operations	9,028				24,864				24,099				52,542
Other income (expense)
Interest expense	(8,895		)		(67		)		(21,158		)		(130		)
Other income (expense), net	(824		)		(1,061		)		(1,588		)		22,602
Total other income (expense)	(9,719		)		(1,128		)		(22,746		)		22,472
Income (loss) before income taxes	(691		)		23,736				1,353				75,014
Income tax provision (benefit)	(543		)		4,370				(325		)		13,826
Net income (loss) and comprehensive income (loss)	$	(148	)		$	19,366			$	1,678			$	61,188
Net income per share:
Basic	$	0.00			$	0.30			$	0.02			$	0.97
Diluted	$	0.00			$	0.30			$	0.02			$	0.94
Weighted-average number of shares used in computing net income per share:
Basic	72,343				64,220				71,669				63,289
Diluted	72,343				65,583				72,971				64,785

HealthEquity, Inc. and its subsidiaries
Condensed consolidated statements of cash flows (unaudited)
	Six months ended July 31,
(in thousands)		2020				2019
Cash flows from operating activities:
Net income	$	1,678			$	61,188
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	56,106				9,722
Stock-based compensation	18,834				13,618
Amortization of debt issuance costs	2,533				31
Gains on marketable equity securities	—				(27,285		)
Other non-cash items	1,925				—
Deferred taxes	(568		)		7,868
Changes in operating assets and liabilities:
Accounts receivable	(152		)		(1,689		)
Other assets	(3,187		)		(4,962		)
Operating lease right-of-use assets	5,563				1,286
Accounts payable	6,047				(1,083		)
Accrued compensation	(13,854		)		(5,926		)
Accrued liabilities and other current liabilities	(6,017		)		4,942
Operating lease liabilities, non-current	(5,723		)		(1,210		)
Other long-term liabilities	5,477				331
Net cash provided by operating activities	68,662				56,831
Cash flows from investing activities:
Purchases of property and equipment	(8,987		)		(3,492		)
Purchases of software and capitalized software development costs	(21,787		)		(9,518		)
Acquisition of intangible member assets	(24,922		)		(1,736		)
Purchases of marketable securities	—				(53,845		)
Net cash used in investing activities	(55,696		)		(68,591		)
Cash flows from financing activities:
Proceeds from follow-on equity offering, net of payments for offering costs	287,318				458,881
Principal payments on long-term debt	(215,625		)		—
Settlement of client-held funds obligation, net	(10,292		)		—
Proceeds from exercise of common stock options	2,817				6,564
Net cash provided by financing activities	64,218				465,445
Increase in cash and cash equivalents	77,184				453,685
Beginning cash and cash equivalents	191,726				361,475
Ending cash and cash equivalents	$	268,910			$	815,160

HealthEquity, Inc. and its subsidiaries
Condensed consolidated statements of cash flows (unaudited) (continued)
	Six months ended July 31,
(in thousands)		2020				2019
Supplemental cash flow data:
Interest expense paid in cash	$	17,659			$	101
Income taxes paid in cash, net of refunds received	798				9,119
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable or accrued liabilities	$	1,104			$	3
Purchases of software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation	1,262				487
Purchases of intangible member assets	58				6,500
Additions to goodwill due to measurement period adjustments	1,177				—
Exercise of common stock options receivable	66				87
Follow-on equity offering costs accrued during the period	540				386
Debt issuance costs accrued during the period	—				345

Stock-based compensation expense (unaudited)
Total stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive income is as follows:
	Three months ended July 31,								Six months ended July 31,
(in thousands)		2020				2019				2020				2019
Cost of revenue	$	2,065			$	1,010			$	3,528			$	1,869
Sales and marketing	1,818				1,158				2,776				2,166
Technology and development	2,493				1,930				5,410				3,429
General and administrative	5,062				3,492				7,120				6,154
Total stock-based compensation expense	$	11,438			$	7,590			$	18,834			$	13,618

Total Accounts (unaudited)
(in thousands, except percentages)	July 31, 2020			July 31, 2019			% Change				January 31, 2020
HSAs	5,384			4,163			29		%		5,344
New HSAs from Sales - Quarter-to-date	108			126			(14	)	%		379
New HSAs from Sales - Year-to-date	213			215			(1	)	%		724
New HSAs from Acquisitions - Year-to-date	—			—			n/a				757
HSAs with investments	284			187			52		%		220
CDBs	7,090			680			943		%		7,437
Total Accounts	12,474			4,843			158		%		12,781
Average Total Accounts - Quarter-to-date	12,416			4,797			159		%		12,603
Average Total Accounts - Year-to-date	12,602			4,739			166		%		8,013

HSA Assets (unaudited)
(in millions, except percentages)		July 31, 2020				July 31, 2019			% Change				January 31, 2020
HSA cash with yield (1)	$	8,626			$	6,460			34	%		$	8,301
HSA cash without yield (2)		344				—			n/a				383
Total HSA cash	8,970				6,460				39	%		8,684
HSA investments with yield (1)	3,046				2,056				48	%		2,495
HSA investments without yield (2)	195				—				n/a			362
Total HSA investments	3,241				2,056				58	%		2,857
Total HSA Assets	12,211				8,516				43	%		11,541
Average daily HSA cash with yield - Year-to-date	8,332				6,404				30	%		6,937
Average daily HSA cash with yield - Quarter-to-date	$	8,380			$	6,402			31	%		$	7,791
(1) HSA Assets that generate custodial revenue.
(2) HSA Assets that do not generate custodial revenue.

Client-held funds (unaudited)
(in millions, except percentages)		July 31, 2020				July 31, 2019			% Change			January 31, 2020
Client-held funds (1)	$	840			$	—			n/a		$	779
Average daily Client-held funds - Year-to-date (1)	861				—				n/a		382
Average daily Client-held funds - Quarter-to-date (1)	891				—				n/a		727
(1) Client-held funds that generate custodial revenue. The Company did not have material Client-held funds prior to the WageWorks acquisition.

Net income reconciliation to Adjusted EBITDA (unaudited)
	Three months ended July 31,								Six months ended July 31,
(in thousands)		2020				2019				2020				2019
Net income (loss)	$	(148	)		$	19,366			$	1,678			$	61,188
Interest income	(76		)		(1,884		)		(676		)		(3,227		)
Interest expense	8,895				67				21,158				130
Income tax provision (benefit)	(543		)		4,370				(325		)		13,826
Depreciation and amortization	9,522				3,455				18,327				6,737
Amortization of acquired intangible assets	19,077				1,494				37,779				2,985
Stock-based compensation expense	11,438				7,590				18,834				13,618
Merger integration expenses	10,365				2,784				23,135				2,784
Acquisition costs (gains)	(28		)		6,596				66				7,780
Gain on marketable equity securities	—				(3,774		)		—				(27,285		)
Other (1)	1,500				579				3,034				1,030
Adjusted EBITDA	$	60,002			$	40,643			$	123,010			$	79,566
(1)    For the three months ended July 31, 2020 and 2019, Other consisted of amortization of incremental costs to obtain a contract of $569 and $456, non-income-based taxes of $390 and $108, and other costs of $541 and $15, respectively. For the six months ended July 31, 2020 and 2019, Other consisted of amortization of incremental costs to obtain a contract of $834 and $900, non-income-based taxes of $832 and $121, and other costs of $1,368 and $9, respectively.

Reconciliation of net loss outlook to Adjusted EBITDA outlook (unaudited)
	Outlook for the
(in millions)	year ending January 31, 2021
Net loss	$(13) - (5)
Interest income	(2)
Interest expense	37
Income tax benefit	(5) - (3)
Depreciation and amortization	38
Amortization of acquired intangible assets	76
Stock-based compensation expense	42
Merger integration expenses	48
Other	5
Adjusted EBITDA	$226 - 236

Reconciliation of net income (loss) to non-GAAP net income (unaudited)
	Three months ended July 31,								Six months ended July 31,								Outlook for the
(in millions, except per share data)		2020				2019				2020				2019			year ending January 31, 2021
Net income (loss)	$	0			$	19			$	2			$	61			$(13) - (5)
Income tax provision (benefit)	(1		)		5				(1		)		14				(5) - (3)
Income (loss) before income tax provision (benefit) - GAAP	(1		)		24				1				75				(18) - (8)
Non-GAAP adjustments:
Amortization of acquired intangible assets	19				1				38				3				76
Stock-based compensation expense	12				8				19				14				42
Merger integration expenses	10				3				23				2				48
Acquisition costs	—				7				—				8				—
Gain on marketable equity securities	—				(4		)		—				(27		)		—
Total adjustments to GAAP income before income tax provision	41				15				80				—				166
Income before income tax provision - Non-GAAP	40				39				81				75				148 - 158
Income tax provision - Non-GAAP (1)	10				10				20				19				37 - 39
Non-GAAP net income	30				29				61				56				111 - 119
Diluted weighted-average shares	72				66				73				65				75
Non-GAAP net income per diluted share (2)	$	0.42			$	0.44			$	0.83			$	0.87			$1.48 - 1.58
(1) The Company utilizes a normalized non-GAAP tax rate to provide better consistency across the interim reporting periods within a given fiscal year by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency, and which are not necessarily reflective of the Company’s longer-term operations. The normalized non-GAAP tax rate applied to each period presented was 25%. The Company may adjust its non-GAAP tax rate as additional information becomes available and in conjunction with any other significant events occur that may materially affect this rate, such as merger and acquisition activity, changes in business outlook, or other changes in expectations regarding tax regulations.
(2) Non-GAAP net income per diluted share may not calculate due to rounding of non-GAAP net income and diluted weighted-average shares.

Certain terms
Term		Definition
HSA		A financial account through which consumers spend and save long-term for healthcare on a tax-advantaged basis.
CDB		Consumer-directed benefits offered by employers, including flexible spending and health reimbursement arrangements (“FSAs” and “HRAs”), Consolidated Omnibus Budget Reconciliation Act (“COBRA”) administration, commuter and other benefits.
HSA member		Consumers with HSAs that we serve.
Total HSA Assets		HSA members' deposits with our federally insured custodial depository partners and custodial cash deposits invested in an annuity contract with our insurance company partner. Total HSA Assets also includes HSA members' investments in mutual funds through our custodial investment fund partner.
Client		Our employer clients.
Total Accounts		The sum of HSAs and CDBs on our platforms.
Client-held funds		Deposits held on behalf of our Clients to facilitate administration of our CDBs
Network Partner		Our health plan partners, benefits administrators, and retirement plan recordkeepers.
Adjusted EBITDA		Adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration and acquisition-related costs, gains and losses on marketable equity securities, and other certain non-operating items.
Non-GAAP net income		Calculated by adding back to net income before provision for income taxes the following items: amortization of acquired intangible assets, stock-based compensation expense, merger integration and acquisition-related costs, and gains and losses on marketable equity securities.
Non-GAAP net income per diluted share		Calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.

FAQ

What was HealthEquity's revenue for Q2 FY21?

HealthEquity reported a revenue of $176.0 million for Q2 FY21.

How did non-GAAP income compare to last year for HealthEquity?

Non-GAAP net income for Q2 FY21 was $30.1 million, up from $28.8 million in Q2 FY20.

What was the total HSA Assets amount for HealthEquity in Q2 FY21?

Total HSA Assets reached $12.2 billion in Q2 FY21.

What are the expected revenues for HealthEquity for FY21?

HealthEquity expects revenues between $720 million and $730 million for FY21.

What is the adjusted EBITDA for HealthEquity in Q2 FY21?

Adjusted EBITDA for Q2 FY21 was $60.0 million, a 48% increase year over year.